In a separate study phosphorylation of GSK3α/β on the inhibitory site, S21/9, was also found to be increased in NSCLC tumour tissue compared to normal, and this too correlated with poor patient prognosis [16]. This evidence concerns the gene GSK3A and neoplasm.